Bionavigen at PEGS Europe 2026

Nov 16–19, 2026 Lisbon, Portugal ~1.5k attendees Website

Bionavigen brings 2 presentations to PEGS Europe 2026 in Lisbon. Its contribution looks past classical antibody-drug conjugates to designing next-generation conjugates for precision, tumour uptake and a wider therapeutic index.

OrganizationPEGS Europe 2026 Attendance
bionavigen.com
Consulting & services
Biopharmaceutical consultancy advising on drug discovery, preclinical and clinical development, and in-licensing of early-stage assets.
Chair
Wed Nov 18
8:25am–8:30am
Chairperson's Remarks
Engineering Next-Generation Conjugates
Talk
Wed Nov 18
8:30am–9:00am

Explore the full PEGS Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Lisbon. Leave your work email and we’ll be in touch.

Privacy

Download the full PEGS Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Bionavigen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PEGS Europe or its organizers. Submit a correction